Gilead Sciences Inc (XSGO:GILD)
$ 65.55 0 (0%) Market Cap: 84.47 Bil Enterprise Value: 104.94 Bil PE Ratio: 188.33 PB Ratio: 4.82 GF Score: 74/100

Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 08:40PM GMT
Release Date Price: $56.95
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good afternoon, everyone, from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Gilead, and Chairman and CEO, Dan O'Day.

Please note that following this presentation, we will have a Q&A session right here in the same Zoom room, and you're able to submit your own questions via the little blue ask-a-question button in the conference portal. So please do that throughout the presentation. We'll get to as many as we can after Dan is finished.

So with that, Dan, thanks for being here today, and let me turn things over to you.

Daniel P. O;Day
Gilead Sciences, Inc. - Chairman & CEO

' -

Great. Thanks, Cory and JPMorgan, for hosting us here. Really appreciate the opportunity to speak to you about Gilead. It is -- just 1 year ago, that was my first JPMorgan with Gilead, and a lot has happened in that year time,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot